Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcus Quinkler

Showing results (201-210 of 209) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 209 results.
European Journal of Endocrinology|June 9, 2025
Expert Consensus on the Primary Aldosteronism Severity Classification and its strategic application in indicating adrenal venous samplingMasanori Murakami, Mitsuhide Naruse, Hiroki Kobayashi, et al.
Ebiomedicine|January 23, 2026
Endocrine and metabolic determinants of cardiometabolic risk in mild autonomous cortisol secretionAlessandro Prete, Lida Abdi, Marco Canducci, et al.
The Lancet. Diabetes & Endocrinology|January 17, 2025
Outcomes after medical treatment for primary aldosteronism: an international consensus and analysis of treatment response in an international cohortJun Yang, Jacopo Burrello, Jessica Goi, et al.
European Journal of Endocrinology|November 9, 2020
ENSAT registry-based randomized clinical trials for adrenocortical carcinomaJoakim Crona, Eric Baudin, Massimo Terzolo, et al.
The Lancet. Diabetes & Endocrinology|January 24, 2026
Effect of surgical versus conservative management on cardiovascular outcomes in patients with bilateral adrenal tumours and cortisol excess: an international, retrospective cohort studyElisabeth Nowak, Charlotte L Viëtor, Richard A Feelders, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism|September 1, 2024
MAML3-fusions modulate vascular and immune tumour microenvironment and confer high metastatic risk in pheochromocytoma and paragangliomaMaría Monteagudo, Bruna Calsina, Milton E Salazar-Hidalgo, et al.
The Lancet. Diabetes & Endocrinology|July 27, 2020
Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation studyIrina Bancos, Angela E Taylor, Vasileios Chortis, et al.
Nature Communications|February 28, 2023
Genomic and immune landscape Of metastatic pheochromocytoma and paragangliomaBruna Calsina, Elena Piñeiro-Yáñez, Ángel M Martínez-Montes, et al.
Endocrine-Related Cancer|April 9, 2025
Genotype-specific neoplastic risk profiles in patients with VHL diseaseAthina Ganner, Alfonso Massimiliano Ferrara, Peggy Sekula, et al.
Pageof 21

Showing results (201-210 of 209) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 209 results.
European Journal of Endocrinology|June 9, 2025
Expert Consensus on the Primary Aldosteronism Severity Classification and its strategic application in indicating adrenal venous samplingMasanori Murakami, Mitsuhide Naruse, Hiroki Kobayashi, et al.
Ebiomedicine|January 23, 2026
Endocrine and metabolic determinants of cardiometabolic risk in mild autonomous cortisol secretionAlessandro Prete, Lida Abdi, Marco Canducci, et al.
The Lancet. Diabetes & Endocrinology|January 17, 2025
Outcomes after medical treatment for primary aldosteronism: an international consensus and analysis of treatment response in an international cohortJun Yang, Jacopo Burrello, Jessica Goi, et al.
European Journal of Endocrinology|November 9, 2020
ENSAT registry-based randomized clinical trials for adrenocortical carcinomaJoakim Crona, Eric Baudin, Massimo Terzolo, et al.
The Lancet. Diabetes & Endocrinology|January 24, 2026
Effect of surgical versus conservative management on cardiovascular outcomes in patients with bilateral adrenal tumours and cortisol excess: an international, retrospective cohort studyElisabeth Nowak, Charlotte L Viëtor, Richard A Feelders, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism|September 1, 2024
MAML3-fusions modulate vascular and immune tumour microenvironment and confer high metastatic risk in pheochromocytoma and paragangliomaMaría Monteagudo, Bruna Calsina, Milton E Salazar-Hidalgo, et al.
The Lancet. Diabetes & Endocrinology|July 27, 2020
Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation studyIrina Bancos, Angela E Taylor, Vasileios Chortis, et al.
Nature Communications|February 28, 2023
Genomic and immune landscape Of metastatic pheochromocytoma and paragangliomaBruna Calsina, Elena Piñeiro-Yáñez, Ángel M Martínez-Montes, et al.
Endocrine-Related Cancer|April 9, 2025
Genotype-specific neoplastic risk profiles in patients with VHL diseaseAthina Ganner, Alfonso Massimiliano Ferrara, Peggy Sekula, et al.
Pageof 21